In this study, we present convincing evidence that FoxO3a can function as a negative regulator of autophagy in cancer cells, including PC3 prostate, MDA-MB-231 breast and HCT116 colon cancer cell lines (Fig. 2). Here, FOXO3 is linked to malignant colon neoplasm.